SUMMIT European Cannabis Insights Summit 2026 — Exclusive industry intelligence Register Now
EVENT Cannabis Europa London 2026 — Europe's cannabis industry unites Get Tickets

Recent Searches

    How to understand cannabis’ impact on alcohol sales in Canada

    By

    The CCSI was assessed at C$5.00 per gram this week, down 1.5% from last week’s C$5.07 per gram. This week’s price equates to US$1,817 per pound at the current exchange rate.

    Each week, Business of Cannabis delivers a series of insights from our partners at Cannabis Benchmarks®.

    This week, Cannabis Benchmarks examines whether legal cannabis sales in Canada have impacted alcohol sales.

    With the legalization of recreational cannabis in October 2018, alcohol companies feared they would see a reduction in sales, as consumers of legal age might opt to substitute cannabis for alcohol. However, data shows that alcohol sales have been growing steadily despite the introduction of legal recreational cannabis sales. Since August 2020, monthly alcohol sales have grown by C$132M to C$2.27B. Meanwhile, monthly legal cannabis sales have grown by C$109M to reach C$357M.

    So far it appears that legal cannabis sales have not eaten into alcohol sales, but Cannabis Benchmarks does believe that, at some point, they will.

    Cannabis sales are already starting to represent a larger portion of the total dollars spent towards alcohol and cannabis. Currently, cannabis’ share stands at 13.6% of the total spend of the combined categories, up from 10.4% in August 2020, and we expect that growth to continue.

    Source: Canada Cannabis Spot IndexCannabis Benchmarks

    See previous weekly updates from Cannabis Benchmarks:



    BofC

    The Briefing / Newsletter

    Insights
    you don't want
    to miss.

    A comprehensive, thoughtfully curated overview of the stories defining today's cannabis sector — breaking news, investigative features, expert commentary, and context-rich analysis to help you navigate events with clarity and confidence.

    • Policy & regulation
    • Markets & deals
    • Clinical & science
    Subscribe free